Researchers at the University of Adelaide in South Australia have shown that that there is an inverse relationship between PSA levels in the blood and the body mass of the men being tested. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: obesity, PSA, risk | 3 Comments »
Overweight and obese prostate cancer patients are often advised to lose weight prior to surgery for the treatment of localized forms of prostate cancer. But is this really, always, a good idea? … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: loss, obesity, overweight, pre-surgery, prostatectomy, radical, weight | 2 Comments »
It is well understood that there is an association between obesity and future risk for prostate cancer-specific mortality among cancer-free men. What has not been so clear is the relationship between obesity and long-term outcomes, post-treatment, among men diagnosed early with localized disease … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: BMI, mortality, obesity, outcomes, overweight, radical prostatectomy | 2 Comments »
A new report from the International Agency Research on Cancer (IARC) Handbook Working Group has concluded that there is a definitive link between “body fatness” and increased risk for diagnosis with 13 different types of cancer — but prostate cancer is not on that list. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, fatness, obesity, overweight, risk | Leave a comment »
By using data from the prospective SELECT trial (the Selenium and Vitamin E Cancer Prevention Trial, conducted between 2001 and 2011), researchers have been able to suggest that obesity is strongly associated with increased risk for prostate cancer diagnosis among African American males compared to non-Hispanic whites. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: BMI, body mass, Diagnosis, obesity, risk | Leave a comment »
A new report issued here in the USA by the American Institute for Cancer Research (AIRC) and globally by the World Cancer Research Fund International is focused on “Diet, Nutrition, Physical Activity and Prostate Cancer“. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: activity, diet, nutrition, obesity, Prevention, risk | Leave a comment »
The American Society of Clinical Oncology (ASCO) has just published its first-ever policy statement on obesity and cancer, and is warning that “obesity could soon become the leading cause of cancer” here in America. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Prevention, Risk | Tagged: ASCO, education, obesity, policy, risk | 1 Comment »
There’s been a lot of media noise today about a study just published on line in Cancer Epidemiology, Biomarkers & Prevention. The study indicates an association between obesity and future risk for a diagnosis of prostate cancer but (as we state frequently) an “association” is by no means the same as “cause and effect”. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: obesity, risk | Leave a comment »
Grace Lu-Yao and colleagues have posted an interesting “Beyond the Abstract” commentary on the UroToday web site in relation to recent data about the associations between obesity and prostate cancer in America. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, BMI, body mass index, obesity, risk | 2 Comments »
In this weekend’s prostate cancer news reports, we have addressed recent publications on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, age, biopsy, brachytherapy, diabetes, focal, hormone therapy, mortality, neoadjuvant, obesity, race, single nucleotide polymorphism, SNP, Treatment | Leave a comment »
Some prior studies have suggested a relationship between obesity and adverse pathologic features on prostate biopsy and have suggested that obese patients may be at higher risk for prostate cancer-related death after radical prostatectomy. However, other studies have been unable to demonstrate any relationship between obesity and clinical risks from prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: obesity, risk, saturation biopsy | 1 Comment »
In today’s news reports we comment on:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: adiponectin, adjuvant radiation, biochemical failure, cost, Degarelix, obesity, positive surgical margin, risk, tumor volume | Leave a comment »
Three reports discussed today address the refinement of risk information in the diagnosis and prognosis of prostate cancer, with specific regard to:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: BMI, Gleason score, obesity, percent cancer, PSA, tunor volume, upstaging | Leave a comment »
A new analysis of data from the Shared Equal Access Regional Cancer Hospital (SEARCH) prostate cancer database has suggested that obese men with prostate cancer are at particularly high risk for recurrence of their disease — regardless of race. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: obesity, recurrence, risk | Leave a comment »
In today’s news reports we comment on studies dealing with:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, EBRT, endorectal balloon, external beam radiation, neoadjuvant hormone therapy, obesity, PSA | Leave a comment »
